Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Treatment of Idiopathic Recurrent Pericarditis With Goflikicept: Phase II/III Study Results.

Valentina Yu Myachikova,Alexey L Maslyanskiy,Olga M Moiseeva, Oksana V Vinogradova, Ekaterina V Gleykina,Yan Lavrovsky,Antonio Abbate,Sergey A Grishin,Alina N Egorova, Margarita L Schedrova,Mikhail Yu Samsonov

Journal of the American College of Cardiology（2023）

Cited 0|Views5
No score
Abstract
Treatment with goflikicept prevented recurrences and maintained IRP remission with a favorable risk-benefit ratio. Goflikicept reduced the risk of recurrence compared with placebo. (Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericarditis; NCT04692766).
More
Translated text
Key words
autoinflammatory diseases,biologics,inflammation,interleukin-1 inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined